Ace lab test
Pro Research Analysisby
Searched over 200M research papers
Consensus Meter
ACE Lab Test: Diagnostic and Clinical Applications
Addenbrooke's Cognitive Examination (ACE-III) and mini-ACE for Dementia Detection
Diagnostic Accuracy of ACE-III and mini-ACE
The Addenbrooke's Cognitive Examination III (ACE-III) and its shorter version, the mini-ACE, are cognitive screening tools designed to detect dementia and mild cognitive impairment (MCI). These tools have shown good sensitivity and specificity in various studies, but their diagnostic accuracy has not been thoroughly validated across different settings. A review of seven cross-sectional studies involving 1711 participants revealed that the ACE-III and mini-ACE have variable sensitivity and specificity across different thresholds and patient populations. For instance, the sensitivity of the ACE-III for detecting dementia ranged from 82% to 97%, while its specificity varied more widely from 4% to 77%. Similarly, the mini-ACE showed sensitivity ranges from 70% to 99% for dementia detection, with specificity ranging from 32% to 100%.
Limitations and Recommendations
The studies reviewed did not include primary care settings, and there was significant heterogeneity among the included studies, preventing meta-analysis. The authors concluded that there is insufficient evidence to recommend the ACE-III or mini-ACE as standalone screening tools for dementia or MCI. They suggested that these tools should be used as adjuncts to a full clinical assessment and emphasized the need for further research to determine optimal thresholds and validate these tools in various clinical settings.
Conformational Fingerprinting of ACE: Personalized Medicine Approach
Methodology and Sensitivity
The conformational fingerprinting of angiotensin I-converting enzyme (ACE) using monoclonal antibodies (mAbs) is a novel approach that provides a sensitive marker for detecting subtle conformational changes in ACE. This method can identify differences in ACE conformation due to mutations, glycosylation variations, and the presence of inhibitors or effectors. The mAbs-based assay has been shown to be more sensitive than traditional kinetic assays, making it a valuable tool for personalized medicine.
Clinical Relevance
This approach allows for the detection of inter-individual differences in ACE conformation, which can be crucial for tailoring ACE inhibitor treatments to individual patients. The methodology can also be applied to other enzymes or proteins with available mAbs, potentially broadening its clinical applications.
Serum ACE Levels in Sarcoidosis: Diagnostic and Monitoring Tool
Increased Sensitivity in Sarcoidosis Detection
Serum ACE measurement is a useful diagnostic and monitoring tool for sarcoidosis. A study identified a serum ACE inhibitor that can affect ACE activity measurements. By diluting the serum sample, the effect of the inhibitor can be eliminated, increasing the sensitivity of the ACE assay for detecting active sarcoidosis. This finding underscores the importance of proper sample preparation in obtaining accurate ACE measurements.
Longitudinal Monitoring
Longitudinal studies have shown that serum ACE levels correlate well with the clinical status of sarcoidosis patients and their gallium scan results. Serial measurements of serum ACE can be a sensitive means for tracking the clinical course of sarcoidosis, potentially predicting relapses or improvements. This makes serum ACE a valuable biomarker for both diagnosis and ongoing management of the disease.
Conclusion
The ACE lab test encompasses a range of diagnostic and monitoring tools with applications in cognitive impairment and sarcoidosis. While the ACE-III and mini-ACE show promise for dementia screening, further validation is needed. Conformational fingerprinting of ACE offers a personalized approach to treatment, and serum ACE levels provide a reliable marker for sarcoidosis management. Continued research and refinement of these methods will enhance their clinical utility.
Sources and full results
Most relevant research papers on this topic